CATX.US FORM ROUNDING BOTTOM
US Cancer Drug Company $Perspective Therapeutics(CATX.US$ received widespread market attention at two separate industry conferences this week as pharmaceutical giants spend billions of dollars to acquire startups that develop new methods of treating cancer using radiation.
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also known as nuclear drugs) boom, investors saw the growth potential of $Perspective Therapeutics(CATX.US$ and the company's CEO Thijs Spoor also praised the disruptive potential of nuclear medicine at one of the events.
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also known as nuclear drugs) boom, investors saw the growth potential of $Perspective Therapeutics(CATX.US$ and the company's CEO Thijs Spoor also praised the disruptive potential of nuclear medicine at one of the events.
Uptrend 📈 Target Price 1.80 Support 1.45
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Learn more Know more Earn more 📈
Technical + Fundamental Investment
279Followers
16Following
555Visitors
Follow
Kevin Lehmann : todays decline just a bigger spinng top will be bullish soon